2020-05-22T13:25:41-06:00

HAE Canada is excited to announce that our new and improved website officially went live today, May 22, 2020. This project was made possible through our partnership with HAE International (HAEi), which is graciously hosting

2020-05-22T13:25:41-06:00

Great News!

2020-05-20T15:36:22-06:00

HAEGARDA and TAKHZYRO are now available in Canada. Please talk to your HAE specialist about access. Thank you Canadian Blood Services (CBS) for a very collaborative, informative and team building HAE Forum. The care for

Great News!2020-05-20T15:36:22-06:00

HAE Day 2020

2020-05-20T07:37:08-06:00

For HAE Day 2020, HAE Canada wants to celebrate! To honour the day we have two BIG announcements: 1) Our website received a facelift! We hope our members find the updated content and new

HAE Day 20202020-05-20T07:37:08-06:00

Virtual HAE Global Walk

2020-04-29T13:40:08-06:00

It’s time, once again, for HAE Canada to please ask you to take out your walking shoes and participate in the virtual HAE Global Walk arranged by HAE International. HAE Canada is encouraging our members,

Virtual HAE Global Walk2020-04-29T13:40:08-06:00

HAE Canada’s message on COVID-19

2020-05-01T22:21:12-06:00

HAE Canada continues to remain focused on the health and well-being of patients with hereditary angioedema, and other related angioedema, in Canada. We would like to share what information we have gathered regarding the COVID-19

HAE Canada’s message on COVID-192020-05-01T22:21:12-06:00

HAEGARDA is available in Quebec

2020-05-20T11:42:03-06:00

We are thrilled to let the HAE community know that HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) is now available to HAE patients in Quebec. HAEGARDA is a subcutaneous C1 esterase inhibitor (C1-INH) therapy indicated for

HAEGARDA is available in Quebec2020-05-20T11:42:03-06:00